# Applyo Jena

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/applyo-jena

- Industry: Healthcare
- Headquarters: Jena, Germany
- Website: www.applyo-jena.com
- Latest round: Series A (May 8, 2025)
- Investors on record: 3

## About

Applyo Jena is a biotechnology company focused on innovative freeze-dried reagents, enhancing laboratory efficiency through their unique Applyo Beads designed for molecular biology applications. Founded in 2021 in Jena, Germany, Applyo Jena develops freeze-dried reagents for various molecular biology applications. In May 2025, the company raised an undisclosed amount of series A funding from Bm-t, with participation from LBBW Venture Capital, Robert Bosch Venture Capital, and an individual investor. Applyo Jena specializes in the design and supply of freeze-dried reagents, particularly their innovative Applyo Beads, which offer significant advantages over traditional liquid reagents. These beads come in various sizes and volumes, ranging from 2 µL to over 250 µL, catering to diverse applications in molecular biology, including RT-qPCR, PCR, and isothermal amplification methods. The company targets biopharmaceutical companies, diagnostics suppliers, and life science organizations that require stable, ready-to-use reagents for their research and development needs. Additionally, Applyo Jena provides extensive support services, including the development of freeze-drying formulations and contract manufacturing, thereby assisting customers in streamlining their laboratory processes. Applyo Jena generates revenue through a structured business model that includes both direct sales and partnerships within the life sciences sector. Their transactions typically involve B2B engagements, where clients can purchase customized and standard Applyo Beads based on their specific needs, facilitating streamlined laboratory operations. The company also engages in contracts for the development and manufacturing of reagents, leveraging its proprietary lyophilization technology. While specific pricing details for their offerings are not disclosed, the focus remains on providing cost-effective solutions that enhance efficiency in research and diagnostics, reinforcing the positioning of Applyo Beads as reliable products in molecular diagnostics. Applyo Jena is focused on expanding its product offerings with new designs of Applyo Beads scheduled for release in 2025. The company will use the May 2025 funding to scale production, expand its diagnostics business, and venture into the pharmaceutical sector.

## Funding rounds

- Series A, May 8, 2025 — LBBW Venture Capital, Robert Bosch Venture Capital, Bm-t
- Series A, Feb 18, 2025 — LBBW Venture Capital, Robert Bosch Venture Capital

## Investors

- LBBW Venture Capital (https://capitalatlas.ai/funds/lbbw-venture-capital) — Series A
- Robert Bosch Venture Capital (https://capitalatlas.ai/funds/robert-bosch-venture-capital) — Series A
- Bm-t (https://capitalatlas.ai/funds/bm-t) — Series A